KLING DOUGLAS F

PrivateCIK: 1699022
Location

BEDMINSTER, NJ

KLING DOUGLAS F (Chief Operating Officer) sold 61.6% of their position (70.44K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market

Insider sale on the open market — a major position exit. Check remaining position size for full context.

S · 3 sales
InsiderKLING DOUGLAS FCIK 1699022
Officer· Chief Operating Officer
Since Dec 2023
-70.44K
Net shares
Net seller
$0.00
Total acquired
3
Open market trades
0B · 3S
7
Total transactions
70.44K acquired · 140.88K disposed
Non-Derivative Transactions5

Ordinary Shares

Direct
M · Option Exercise

Shares

+56.86K

Price / share

Trade value

% of position

129.2%
1/29/2025
44K100.86K

Ordinary Shares

Direct
S · Sale

Shares

56.86K

Price / share

Trade value

% of position

56.4%
1/29/2025
100.86K44K

Ordinary Shares

Direct
M · Option Exercise

Shares

+13.58K

Price / share

Trade value

% of position

30.9%
1/30/2025
44K57.58K

Ordinary Shares

Direct
S · Sale

Shares

4.66K

Price / share

Trade value

% of position

8.1%
1/30/2025
57.58K52.91K

Ordinary Shares

Direct
S · Sale

Shares

8.91K

Price / share

Trade value

% of position

16.8%
1/30/2025
52.91K44K
Total

Net shares

+0.00

Net value

$0.00

Derivative Transactions2

Option (right to buy)

Direct
M · Option Exercise
Converts to

Ordinary Shares

56.86K shares

Shares

56.86K

Strike price

Held after

239.72K

Exercisable

1/29/2025

Option (right to buy)

Direct
M · Option Exercise
Converts to

Ordinary Shares

13.58K shares

Shares

13.58K

Strike price

Held after

226.15K

Exercisable

1/30/2025
KLING DOUGLAS F — Insider Transaction (Form 4) Filed Jan 31, 2025 | Finecho